Top in endocrinology: Gut microbiome and diabetes risk; COVID-19 exposure and weight gain

Children who were diagnosed with type 1 diabetes had differences in their gut microbiome at age 1 year from those without diabetes, according to recent data.

Researchers said the findings suggest that gut microbiome composition during infancy may be used to predict future diabetes risk.

“Screening children at birth for genetic risk and monitoring gut health over time would be helpful and allow for dietary or probiotic interventions to improve gut health,” Eric W. Triplett, PhD, a professor and chair of the department of microbiology and cell science at the University of Florida, told Healio. It was the top story in endocrinology last week.

The second top story covered a study that found mothers who contracted COVID-19 during pregnancy were more likely to have infants born with a lower weight and greater weight gain in their first year of life.

Read these and more top stories in endocrinology below:

Gut microbiome during infancy may predict future type 1 diabetes

Children who develop type 1 diabetes may have biomarkers present in the gut microbiome as early as age 1 year, according to a study published in Diabetologia. Read more.

Infants exposed to COVID-19 in utero gain more weight during first year of life

Mothers who contract COVID-19 during pregnancy are more likely to have infants with a lower birth weight and greater weight gain during the first year of life compared with mothers who did not have COVID-19, according to study data. Read more.

Advanced hybrid closed-loop therapy reduces HbA1c for adolescents with type 1 diabetes

Advanced hybrid closed-loop therapy reduces HbA1c and improves time in range among adolescents and young adults with type 1 diabetes, with few serious adverse events, according to findings published in Diabetes Care. Read more.

Verapamil partially preserves C-peptide levels among youths with type 1 diabetes

Once-daily oral verapamil may help preserve stimulated C-peptide secretion for children and adolescents with type 1 diabetes, according to a study published in JAMA. Read more.

Cognitive behavioral therapy-based intervention reduces diabetes distress for adults

A cognitive behavioral therapy multidisciplinary intervention was associated with a reduction in HbA1c and improvements in diabetes distress for adults with type 1 and type 2 diabetes, according to study findings. Read more.